Abstract | PURPOSE: METHODS: In vitro studies (using a crystal violet cell survival assay) of the interaction of hyperthermia with D-19575, as well as the activated form of ifosfamide (4-hydroperoxy-ifosfamide, D-18851), were performed using L929 and OVCAR-3 cell lines held at various temperatures (i.e. 37 degrees C (control), 40.5 degrees C, 41.8 degrees C, 42.5 degrees C, and 43 degrees C) for 65 min. RESULTS: The following thermal enhancement ratios (TER) were demonstrated: D-19575 in L929 1.2, 2.0 and 2.3 at 40.5, 41.8 and 42.5 degrees C, respectively; for D-18851 in L929 1.7 at 41.8 degrees C; for D-19575 in OVCAR-3 2.1, 3.2 and 3.3 at 40.5, 41.8 and 42.5 degrees C, respectively; for D-18851 in OVCAR-3 4.6 at 41.8 degrees C. CONCLUSION: The significant observed increase in cytotoxicity of D-19575 caused by hyperthermia taken together with its known preclinical toxicity profile, encourage its further preclinical and ultimately clinical testing, including its use with whole body and regional hyperthermia.
|
Authors | M E Kutz, D L Mulkerin, G J Wiedemann, D M Katschinski, H I Robins |
Journal | Cancer chemotherapy and pharmacology
(Cancer Chemother Pharmacol)
Vol. 40
Issue 2
Pg. 167-71
( 1997)
ISSN: 0344-5704 [Print] Germany |
PMID | 9182839
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- beta-D-glucosylisophosphoramide mustard
- Glucose
- Ifosfamide
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Cell Survival
(drug effects)
- Glucose
(analogs & derivatives, pharmacology)
- Humans
- Hyperthermia, Induced
- Ifosfamide
(analogs & derivatives, pharmacology)
- Tumor Cells, Cultured
|